Why should you invest in Mabion S.A.?
- Mabion S.A. is a leading biotechnology company in Poland.
- It operates on an attractive biosimilar market, one of the most dynamically developing areas in the global pharmaceutical industry.
- Mabion has been developing an attractive portfolio of biosimilar drugs whose reference drugs have a global reach on a market which is worth over USD 20 billion.
- The use of cutting edge technologies, such as orbital shaking and disposable technologies, allows Mabion S.A. to achieve high profit margins and an equally impressive level of production efficiency.
- Our employees have rich experience, both in management and in biotechnology, and the last eight years at Mabion S.A. have turned them into a perfect team.
- We also have great potential when it comes to establishing partnerships with the biggest players in the global pharmaceutical and biotech industry.